• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项针对老年人停用抗高血压治疗的5年前瞻性观察性研究。

A 5-year prospective, observational study of the withdrawal of antihypertensive treatment in elderly people.

作者信息

Ekbom T, Lindholm L H, Odén A, Dahlöf B, Hansson L, Wester P O, Scherstén B

机构信息

Health Sciences Centre, Lund University, Dalby/Lund, Sweden.

出版信息

J Intern Med. 1994 Jun;235(6):581-8. doi: 10.1111/j.1365-2796.1994.tb01265.x.

DOI:10.1111/j.1365-2796.1994.tb01265.x
PMID:8207364
Abstract

OBJECTIVES

To observe blood pressure, cardiovascular events, and total mortality after withdrawing antihypertensive treatment for elderly patients.

DESIGN

Multicentre observational study.

SETTING

Sweden. A 5-year follow-up of 333 elderly hypertensive patients, aged 70-84 years (mean age 75.2 +/- SD 3.8 years, 68% females). In all, 74 out of the 333 patients (22%) died during the study period.

METHOD

After withdrawal of the antihypertensive therapy, all patients started in the untreated state and during the 5-year follow-up they could then either remain in the untreated state, or be reverted to blood-pressure-lowering drug treatment because of hypertension or other diseases, e.g. angina pectoris, oedema, congestive heart failure, etc.

RESULTS

The probability of remaining without treatment for 5 years was estimated to be 20%. During the state of no treatment the patients had a lower total mortality risk than that of the general Swedish population, matched for age and sex. They also had a lower risk of cardiovascular events than those in the treated states. Markers indicating a successful withdrawal were monotherapy in low doses and relatively low blood pressure before withdrawal.

CONCLUSION

These results suggest that with frequent check-ups, withdrawal of antihypertensive therapy in the elderly can be tried without increased risk of cardiovascular events.

摘要

目的

观察老年患者停用抗高血压治疗后的血压、心血管事件及总死亡率。

设计

多中心观察性研究。

地点

瑞典。对333名70 - 84岁(平均年龄75.2±标准差3.8岁,68%为女性)的老年高血压患者进行了5年随访。在研究期间,333名患者中有74名(22%)死亡。

方法

停用抗高血压治疗后,所有患者开始处于未治疗状态,在5年随访期间,他们可以一直处于未治疗状态,或者因高血压或其他疾病(如心绞痛、水肿、充血性心力衰竭等)而恢复降压药物治疗。

结果

估计有20%的患者能持续5年不接受治疗。在未治疗状态下,患者的总死亡风险低于年龄和性别匹配的瑞典普通人群。他们发生心血管事件的风险也低于接受治疗状态的患者。表明停药成功的指标是低剂量单药治疗和停药前相对较低的血压。

结论

这些结果表明,通过频繁检查,可以尝试在老年患者中停用抗高血压治疗而不增加心血管事件风险。

相似文献

1
A 5-year prospective, observational study of the withdrawal of antihypertensive treatment in elderly people.一项针对老年人停用抗高血压治疗的5年前瞻性观察性研究。
J Intern Med. 1994 Jun;235(6):581-8. doi: 10.1111/j.1365-2796.1994.tb01265.x.
2
The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.老年人认知与预后研究(SCOPE):一项随机双盲干预试验的主要结果
J Hypertens. 2003 May;21(5):875-86. doi: 10.1097/00004872-200305000-00011.
3
Hypertension in middle-aged men. Management, morbidity and prognostic factors during long-term hypertensive care.中年男性高血压。长期高血压护理中的管理、发病率及预后因素。
Acta Med Scand Suppl. 1985;702:1-79.
4
Sex-specific cardiovascular morbidity and mortality in a cohort treated for hypertension.高血压治疗队列中的性别特异性心血管发病率和死亡率。
J Hypertens. 2006 Aug;24(8):1523-9. doi: 10.1097/01.hjh.0000239287.10013.e0.
5
Effect of antihypertensive treatment on cardiovascular events in elderly hypertensive patients: Japan's Benidipine Research on Antihypertensive Effects in the Elderly (J-BRAVE).老年高血压患者降压治疗对心血管事件的影响:日本老年高血压降压效果研究(J-BRAVE)。
Clin Exp Hypertens. 2011;33(2):133-40. doi: 10.3109/10641963.2010.546467. Epub 2011 Jan 26.
6
Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.高血压患者随机接受多沙唑嗪与氯噻酮治疗后的主要心血管事件:抗高血压和降脂治疗预防心脏病发作试验(ALLHAT)。ALLHAT协作研究组
JAMA. 2000 Apr 19;283(15):1967-75.
7
Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment.20年成功抗高血压治疗期间心血管事件的分布及决定因素
J Hypertens. 1998 Jun;16(6):761-9. doi: 10.1097/00004872-199816060-00007.
8
Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).奥美沙坦与钙拮抗剂随机对照(OSCAR)研究的原理、设计及患者基线特征:一项比较日本老年高危高血压患者中高剂量血管紧张素II受体阻滞剂(ARB)单药治疗与ARB联合钙通道阻滞剂治疗心血管事件发生率的研究(ClinicalTrials.gov编号:NCT00134160)
Hypertens Res. 2009 Jul;32(7):575-80. doi: 10.1038/hr.2009.60. Epub 2009 May 15.
9
Association between cardiovascular outcomes and antihypertensive drug treatment in older women.老年女性心血管结局与降压药物治疗之间的关联
JAMA. 2004 Dec 15;292(23):2849-59. doi: 10.1001/jama.292.23.2849.
10
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).高危高血压患者随机接受血管紧张素转换酶抑制剂或钙通道阻滞剂与利尿剂治疗的主要结局:抗高血压和降脂治疗预防心脏病发作试验(ALLHAT)
JAMA. 2002 Dec 18;288(23):2981-97. doi: 10.1001/jama.288.23.2981.

引用本文的文献

1
Withdrawal of antihypertensive drugs in older people.老年人停用抗高血压药物
Cochrane Database Syst Rev. 2025 Mar 31;3(3):CD012572. doi: 10.1002/14651858.CD012572.pub3.
2
Interventions aimed to increase average 24-h systolic blood pressure reduce blood pressure drops in patients with reflex syncope and orthostatic intolerance.旨在提高平均 24 小时收缩压的干预措施可减少反射性晕厥和直立不耐受患者的血压下降。
Europace. 2024 Feb 1;26(2). doi: 10.1093/europace/euae026.
3
The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
OPTIMIZE 患者和家属为中心、基于初级保健的老年痴呆或轻度认知障碍和多种慢性病患者药物减量干预方案:一项实用型群组随机对照试验的研究方案。
Trials. 2020 Jun 18;21(1):542. doi: 10.1186/s13063-020-04482-0.
4
Withdrawal of antihypertensive drugs in older people.老年人停用抗高血压药物
Cochrane Database Syst Rev. 2020 Jun 10;6(6):CD012572. doi: 10.1002/14651858.CD012572.pub2.
5
Hypertension and Drug Adherence in the Elderly.老年人的高血压与药物依从性
Front Cardiovasc Med. 2020 Apr 7;7:49. doi: 10.3389/fcvm.2020.00049. eCollection 2020.
6
Going Beyond the Guidelines in Individualising the Use of Antihypertensive Drugs in Older Patients.超越指南:个体化使用抗高血压药物治疗老年患者。
Drugs Aging. 2019 Aug;36(8):675-685. doi: 10.1007/s40266-019-00683-8.
7
Deprescribing: Fashion Accessory or Fig Leaf?减药:时尚配饰还是遮羞布?
Pharmacy (Basel). 2019 May 23;7(2):49. doi: 10.3390/pharmacy7020049.
8
Screening and treatment of hypertension in older adults: less is more?老年人高血压的筛查与治疗:少即是多?
Public Health Rev. 2018 Sep 3;39:26. doi: 10.1186/s40985-018-0101-z. eCollection 2018.
9
Withdrawal of antihypertensive medication: a systematic review.停用抗高血压药物:一项系统评价。
J Hypertens. 2017 Sep;35(9):1742-1749. doi: 10.1097/HJH.0000000000001405.
10
Antihypertensive withdrawal for the prevention of cognitive decline.停用抗高血压药物以预防认知功能减退。
Cochrane Database Syst Rev. 2016 Nov 1;11(11):CD011971. doi: 10.1002/14651858.CD011971.pub2.